News Medical on MSN7d
EU-funded Vigilant network aims to develop broad-spectrum antiviral drugs
Pandemics threaten both human health and the global economy. Vaccines are an essential part of the fight against pandemics, but they are only available months after the outbreak ...
NanoViricides Engages CRO for Phase II Clinical Trial
NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial advancing its broad-spectrum ...
BioPharma Dive3d
Model Medicines Unveils Generative AI, Multi-Modal Therapeutic Pipeline Breakthrough, Demonstrating End-To-End Drug Discovery Capabilities
Multi-Modal Models: A multi-modal discovery approach was implemented that engineered-in potency against the novel target and engineered-out a specific off-target interaction. The NCE library displayed ...
Investornewsbreaks Nanoviricides (NYSE American: NNVC) Partners With CRO To Advance NV-387 Antiviral Drug To Phase II Trials
NanoViricides, Inc. (NYSE American: NNVC) announced it has engaged a Clinical Research Organization (“CRO”) to conduct a Phase II clinical trial for ...
FierceBiotech10d
AI drug discoverer's antiviral reduces COVID in mouse lungs, neutralizes other RNA viruses
Many of the most devastating infectious diseases are caused by RNA viruses, and Model Medicines is working on one compound to ...
The Fresno Bee23d
Multiple Viral Threats Amplify Call for Preparedness with Broad-Spectrum Antivirals
Our lead drug candidate is NV-387, a broad-spectrum antiviral drug that we plan to develop as a treatment of RSV, COVID, Long COVID, Influenza, and other respiratory viral infections, as well as ...